ESMO 2026 INTELLIGENCE · MADRIDKnow what top breast cancer KOLs think about your drug — before, during and after ESMO. Six seats only.Request the brochure →
GRG Health Talk to our team
← Back to insights
Whitepapers · healthcare marketing · 6 December 2023

Understanding Consumer Awareness, Usage Patterns, and Brand Perceptions in 1st and 2nd Line Regimens

Format
Whitepaper
Therapy area
Oncology
Published
Q4 2023
Access
On request · sent by email
What's in the report

Inside the report

  1. 01 Awarenesswhich brands patients and physicians know in first- and second-line regimens
  2. 02 Usage patternshow regimens are chosen, sequenced and switched
  3. 03 Brand perceptionsthe attributes associated with each brand and how they compare
  4. 04 Therapy areas coveredmultiple myeloma, prostate cancer and psoriatic arthritis
  5. 05 The patient journeywhere awareness and perception form along the way
  6. 06 Implicationswhat the findings mean for positioning and messaging
Executive summary

What this report tells you

First- and second-line regimen choice is where brand perception meets clinical reality. This report examines awareness, usage patterns and brand perceptions across three therapy areas, multiple myeloma, prostate cancer and psoriatic arthritis, to show how brands are seen and used in practice.

It follows the patient journey to locate where awareness forms and perceptions harden, compares brands on the attributes that matter to treaters, and draws out the implications for positioning.

The full report is available on request. Leave your details below and our team will email it to you.

HCP Market Pulse · full report

Request the full report.

The complete report — full sample, methodology and every cut — is available on request. Leave your work details and our team will email it to you.

← Back to the report library